Base5 Genomics, Inc. — Form D
Base5 Genomics, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-24. The offering totals $4.2M, of which $4.2M was reported sold. Industry: Other.
Offering
- Filed: 2021-09-24
- Form: D
- Accession: 0001813625-21-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $4.2M
- Amount sold: $4.2M
- Investors: 9
- Date of first sale: 2021-09-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-414466
Issuer
- Name: Base5 Genomics, Inc.
- CIK: 0001813625
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 4136 BRIARWOOD WAY, PALO ALTO, CA, 94306
- Phone: 7076964333
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Chihyu Chien | Director | Palo Alto, CA |
| Solomon Endlich | Director | Palo Alto, CA |
| Jonathan Friedlander | Director | La Jolla, CA |
| YUAN WEI TAI | Director | FREMONT, CA |
| Solomon Endlich | Executive Officer | Palo Alto, CA |
| Solomon Endlich | Promoter | Palo Alto, CA |
| Geoffrey Smith | Director | Palo Alto, CA |
Other filings by this issuer (1)
More